The importance of glucocorticoid receptors in systemic lupus erythaematosus. A systematic review
Authors:
- 1 April 2015
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 14 (4) , 349-351
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Systemic Lupus Erythematosus: A Review of the Disease and Treatment OptionsThe Consultant Pharmacist, 2013
- Pharmacology of glucocorticoids in rheumatoid arthritisCurrent Opinion in Pharmacology, 2010
- The geoepidemiology of systemic lupus erythematosusAutoimmunity Reviews, 2010
- Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patientsGenetics and Molecular Research, 2010
- Negative Relationship Between Expression of Glucocorticoid Receptor α and Disease Activity: Glucocorticoid Treatment of Patients with Systemic Lupus ErythematosusThe Journal of Rheumatology, 2009
- Estrogens and Autoimmune DiseasesAnnals of the New York Academy of Sciences, 2006
- Regulating inflammation by glucocorticoidsNature Immunology, 2006
- Pharmacokinetics and Pharmacodynamics of Systemically Administered GlucocorticoidsClinical Pharmacokinetics, 2005
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB SynthesisScience, 1995